Intensity modulated radiotherapy for elderly bladder cancer patients
Authors:
- Chen-Hsi HsiehCHChen-Hsi Hsieh
- Shiu-Dong ChungSCShiu-Dong Chung
- Pei-Hui ChanPCPei-Hui Chan
- Hsiao-Chun ChangHCHsiao-Chun Chang
- Chi-Huang HsiaoCHChi-Huang Hsiao
- Le-Jung WuLWLe-Jung Wu
- Ngot-Swan ChongNCNgot-Swan Chong
- Yu-Jen ChenYu-Jen Chen
- Li-Ying WangLWLi-Ying Wang
- Yen-Ping HsiehYHYen-Ping Hsieh
- Pei-Wei ShuengPSPei-Wei Shueng
Open Access
- 16 June 2011
- journal article
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 75
Abstract
Background: To review our experience and evaluate treatment planning using intensity-modulated radiotherapy (IMRT) and helical tomotherapy (HT) for the treatment of elderly patients with bladder cancer. Methods: From November 2006 through November 2009, we enrolled 19 elderly patients with histologically confirmed bladder cancer, 9 in the IMRT and 10 in the HT group. The patients received 64.8 Gy to the bladder with or without concurrent chemotherapy. Conventional 4-field "box" pelvic radiation therapy (2DRT) plans were generated for comparison. Results: The median patient age was 80 years old (range, 65-90 years old). The median survival was 21 months (5 to 26 months). The actuarial 2-year overall survival (OS) for the IMRT vs. the HT group was 26.3% vs .37.5%, respectively; the corresponding values for disease-free survival were 58.3% vs. 83.3%, respectively; for locoregional progression-free survival (LRPFS), the values were 87.5% vs. 83.3%, respectively; and for metastases-free survival, the values were 66.7% vs. 60.0%, respectively. The 2-year OS rates for T1, 2 vs. T3, 4 were 66.7% vs. 35.4%, respectively (p = 0.046). The 2-year OS rate was poor for those whose RT completion time greater than 8 weeks when compared with the RT completed within 8 wks (37.9% vs. 0%, p = 0.004). Conclusion: IMRT and HT provide good LRPFS with tolerable toxicity for elderly patients with invasive bladder cancer. IMRT and HT dosimetry and organ sparing capability were superior to that of 2DRT, and HT provides better sparing ability than IMRT. The T category and the RT completion time influence OS rate.Keywords
This publication has 35 references indexed in Scilit:
- Concurrent Chemoradiotherapy With Helical Tomotherapy for Oropharyngeal Cancer: A Preliminary ResultInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Improving bladder cancer treatment with radiotherapy using separate intensity modulated radiotherapy plans for boost and elective fieldsJournal of Medical Imaging and Radiation Oncology, 2010
- Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapyRadiation Oncology, 2009
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06Journal of Clinical Oncology, 2009
- Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancerActa Oncologica, 2004
- Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I TrialJournal of Clinical Oncology, 2004
- Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patientsEuropean Journal of Cancer, 1994
- The Management of Deeply Infiltrating (T 3 ) Bladder Carcinoma: Controlled Trial of Radical Radiotherapy versus Preoperative Radiotherapy and Radical Cystectomy (First Report)British Journal of Urology, 1976